San Diego, CA
Transforming the lives of patients with life-limiting diseases of the nervous system. Acquiring, developing and commercializing transformative medicines.
engrail.comThese are collections Engrail Therapeutics is a part of. Click on the collection name to view similar companies.
Series B
$157,000,000
Series A
$32,000,000
Series A
$32,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Engrail Therapeutics.